WallStSmart

Diversified Healthcare Trust (DHC)vsEquinix Inc (EQIX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Equinix Inc generates 502% more annual revenue ($9.26B vs $1.54B). EQIX leads profitability with a 14.6% profit margin vs -18.6%. DHC appears more attractively valued with a PEG of 1.89. EQIX earns a higher WallStSmart Score of 50/100 (C-).

DHC

Hold

39

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: -0.02

EQIX

Buy

50

out of 100

Grade: C-

Growth: 6.7Profit: 6.5Value: 2.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.55
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DHC.

EQIXSignificantly Overvalued (-38.5%)

Margin of Safety

-38.5%

Fair Value

$626.41

Current Price

$1082.83

$456.42 premium

UndervaluedFair: $626.41Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

EQIX3 strengths · Avg: 8.3/10
Market CapQuality
$106.79B9/10

Large-cap with strong market position

Operating MarginProfitability
21.5%8/10

Strong operational efficiency at 21.5%

EPS GrowthGrowth
22.9%8/10

Earnings expanding 22.9% YoY

Areas to Watch

DHC4 concerns · Avg: 3.5/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$1.83B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.613/10

Elevated debt levels

EQIX4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.613/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.912/10

Expensive relative to growth rate

P/E RatioValuation
74.6x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : DHC

The strongest argument for DHC centers on Price/Book.

Bull Case : EQIX

The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth.

Bear Case : DHC

The primary concerns for DHC are PEG Ratio, Revenue Growth, Market Cap. Debt-to-equity of 1.61 is elevated, increasing financial risk.

Bear Case : EQIX

The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.6x leaves little room for execution misses. Debt-to-equity of 1.61 is elevated, increasing financial risk.

Key Dynamics to Monitor

DHC profiles as a turnaround stock while EQIX is a value play — different risk/reward profiles.

DHC carries more volatility with a beta of 2.33 — expect wider price swings.

EQIX is growing revenue faster at 8.1% — sustainability is the question.

DHC generates stronger free cash flow (28M), providing more financial flexibility.

Bottom Line

EQIX scores higher overall (50/100 vs 39/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diversified Healthcare Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Website →

Equinix Inc

REAL ESTATE · REIT - SPECIALTY · USA

Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.

Visit Website →

Want to dig deeper into these stocks?